Poster Details
Poster assignments will be posted closer to the meeting.
Only those receiving poster assignments from the NCI IMAT Program Director will be required to prepare a poster, though others who are interested in presenting a poster but did not receive an assignment may inquire with the IMAT Program Director (Kelly Crotty at kelly.crotty@nih.gov) who will make sure there is space to accommodate the poster. Each poster should be able to fit on the poster boards, which are 6' by 4' (landscape).
Poster Set Up
All poster presenters will receive a number and an assignment for the day of their poster session. Posters should be set up in the morning on the day of the assigned session and taken down by the end of the day.
Each poster is assigned a number. Please make sure to mount your poster on the board with the number assigned to you on the appropriate day.
Poster Assignments
Day 1 Poster Session - Monday December 16
|
|
---|---|
Yu Gao, Alexandra Naba | Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrix |
Matthew Yi, Abraham Lee, Anshu Agrawal | Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy |
Bruce Armitage, Huaiying Zhang | Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA |
Brian Chiu, Wei Zhang | A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research |
Bruce Cunningham | Rapid and ultrasensitive quantitation of lung cancer ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy |
Kai Chen, Charles McKenna | Novel Bisphosphonate PET Probes for Myeloma Bone Disease |
Ryne Ramaker, Christopher Counter | Development of an ultra-sensitive sequencing platform for tumor mutation profiling of pancreas cancer in patient whole blood |
Eric Duncavage, David Spencer | A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer |
Facundo Fernandez | Triboelectric Nanogenerator Laser Ablation Nanoelectrospray Ionization (TENG LAESI) Mass Spectrometry Imaging to Study Renal Cell Carcinomas |
Connor Grady, Gary Luker | Dynamic Multiplexed Imaging Tools for Probing Chemokine Signaling |
Gloria Sheynkman, Song Stephen Yi | An integrated functional proteomics platform for accelerated discovery of isoform-specific determinants of cancer |
Hanlee Ji | Single cell modeling of cancer mutations |
Hao Yan, Rizal Hariadi | High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes |
Hyungsoon Im | Nano-CRISPR extracellular vesicle sensing system for longitudinal tumor monitoring |
David Issadore, Erica Carpenter | Combining Machine Learning and Nanofluidic Technology for the Multiplexed Diagnosis of Pancreatic Adenocarcinoma |
Jarrod Marto, Justin Kim | New Chemical Tools for Covalent Drug Discovery |
Lusheng Song, Joshua LaBaer | Prevaccine Microbial Immunity Shapes COVID Vaccine Response |
John Yates III, Casimir Bamberger | 3D Proteomics at Single Cell Resolution with Covalent Protein Painting (CPP) |
Jose Javier Bravo-Cordero | Intersectional genetics-based biosensors for dormant cancer cells |
Joshua Breunig | Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis |
Alejandra Patino, Joshua Snyder | Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color |
Jonathan Schneck | Artificial Lymph Nodes, aLN, for Therapeutic T Cell Stimulation |
Jungwoo Lee | Functional and analytical recapitulation of bone remodeling processes on demineralized bone paper |
Ji-Xin Cheng, Xinyan Teng | Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy |
Kate Meyer | A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors |
Gennady Shvets | Metasurface-enabled Inverted Reflection-light Infrared Microscopy (MIRIAM): a new label-free real-time imaging platform for live cells in the medium |
Hossein Tavana, Gary Luker | A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery |
Day 2 Poster Session - Tuesday December 17
|
|
---|---|
Chad Borges | Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions |
Joel Greenberg | Biospecimen analysis with a tabletop 4D specimen radiography system |
Li Ye | Mapping cellular targets of covalent cancer drugs in the entire mammalian body |
Joseph Muretta, Wendy Gordon | Engineering Protein Modulators of Notch Activation for T-cell immunotherapy |
Neel Shah | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates |
Nir Hacohen | RNA-encoded large-scale nanobody libraries for in vitro screening against tumor targets |
Parijat Bhatnagar | T-cell Biofactory for degrading tumor-associated extracellular matrix |
Frances Keer, Paul Blainey | Stitch-seq: A facile and high-throughput method to link pooled genetic perturbations to targeted gene expression |
Wihan Adi, Paul Campagnola, Filiz Yesilkoy | A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. |
Guillem Pratx | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer |
Jonathan Good, Peter Van Galen, Vijay Sankaran | Clonal analysis of cancer by mitochondrial DNA barcoding |
Richard Levenson | CoreView and FIBI for rapid-onsite evaluation and molecular profiling of core-needle breast biopsies. |
Ralph Weissleder | Bioorthogonal probe development for highly parallel in vivo imaging |
Maria Santore | Paper-based Breastmilk Collection System for Facile, In-Home Use |
Sidi Chen | Advanced development of composite gene delivery and CAR engineering systems |
Soma Dhakal | Towards High-Confidence Single-Molecule Detection of miRNA Cancer Biomarkers |
Steven Soper | Molecular Sub-typing Breast Cancer Patients from Blood using Exosomal mRNA and Resistive Pulse Sensing |
Stephen Salipante | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations |
Venktesh Shirure | Microfluidic technology to isolate tumoricidal T-cells from peripheral blood |
Wilhelm Haas, Lecia Sequist | AI Controlled Autonomous Proteomics for Clinical Applications |
Xiaojing Gao | Using synthetic biology to sense oncogenes and program immunity against cancer cells |
Yevgeny Brudno | Transduction Sponges for Rapid and Accessible CAR T Cell Therapy |
Yue Lu | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis |
Yong Zeng, Liang Xu | Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles |
Kristen Naegle | A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides |
Branding on Posters
NOTE: NIH policy requires that NIH/NCI grantees not use government logos such as the NIH Logo and NCI Logo or the IMAT logo on their posters. As the author/presenter of the poster, the appropriate branding on your poster is of your institution; the grant was awarded to your institution.
You should identify your IMAT grant in text, using the following statement:
Funded in part by the National Cancer Institute of the National Institutes of Health, Innovative Molecular Analysis Technologies (IMAT) Program, Grant Number: ____________.
If you are collaborating with an NCI researcher, the NCI Logo still may not be used; that person is to be identified on your poster in the authors' section with “National Cancer Institute, Bethesda, MD” listed as the affiliation, not the NCI logo. The NCI Logo and other NIH/HHS logos are trademarked by HHS and are to be used only when an NCI staff researcher is the author and presenter of a poster.